Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (unspecified eye)
ICD-10 E09.3319 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (unspecified eye).
E09.3319 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by moderate nonproliferative diabetic retinopathy with macular edema in an unspecified eye. This condition arises when certain medications or substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The presence of moderate nonproliferative diabetic retinopathy indicates changes in the retinal blood vessels, which can lead to vision complications. Macular edema, a common complication of diabetic retinopathy, occurs when fluid accumulates in the macula, affecting central vision. Management of this condition often involves controlling blood glucose levels, monitoring HbA1c levels, and addressing the retinopathy through appropriate interventions. Regular eye examinations and timely treatment are crucial to prevent progression to more severe forms of retinopathy or vision loss.
Thorough documentation of diabetes management, including medication history and HbA1c levels.
Patients presenting with new-onset diabetes due to medication, requiring insulin management.
Ensure clear documentation of the drug responsible for diabetes and its management plan.
Detailed retinal examination findings, including grading of retinopathy and presence of macular edema.
Patients with diabetes presenting for routine eye exams or vision changes.
Document all findings related to diabetic retinopathy and any treatments provided.
Used during routine eye exams for diabetic patients.
Document visual acuity, retinal findings, and any treatments provided.
Ophthalmologists should ensure comprehensive documentation of diabetic retinopathy findings.
Medications such as corticosteroids, certain antipsychotics, and some chemotherapy agents are known to induce diabetes mellitus by affecting insulin sensitivity or secretion.
Diabetic retinopathy is diagnosed through a comprehensive eye examination, including retinal imaging and assessment of visual acuity, along with the patient's diabetes history.
